Redmond Asset Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Redmond Asset Management's CLBT Position: Q2 2026 in Review
Redmond Asset Management increased its Cellebrite (CLBT) stake by 0.7% in Q2 2026, buying an estimated $18.4K and bringing the position to 200,203 shares worth $2.92M. The position accounts for 0.73% of the portfolio, ranked #37.
Redmond Asset Management first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.57M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Redmond Asset Management held 200,203 shares of Cellebrite worth $2.92M as of Q2 2026.
- Redmond Asset Management bought 1,389 Cellebrite shares in Q2 2026, an estimated $18.4K.
- Cellebrite made up 0.73% of Redmond Asset Management's portfolio in Q2 2026, its #37 holding.
- Redmond Asset Management first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
- Redmond Asset Management's Cellebrite position peaked at $3.57M in Q3 2025.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Redmond Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.